NEUROONE MEDICAL TECHNOLOGIES Corp
For the period ended Sep 30, 2025. Filed Dec 17, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Dec 17, 2025
NMTC$0.89+0.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 11. EXECUTIVE COMPENSATION
The information required by Item 11 is hereby incorporated by reference from the sections of the 2026 Proxy Statement under the captions “Executive Compensation” and “Proposal No. 1 - Election of Class III Directors - Non-Employee Director Compensation – 2025 Compensation.”
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.